Advertisement Research ArticleCell biologyHepatologyMetabolism Open Access | 10.1172/JCI197556 1 Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
What the tolerability data suggests Escitalopram has a slightly higher discontinuation rate due to adverse events than placebo, 7.2% versus 4.3% , and it is often viewed as more tolerable than paroxetine in comparative discussions of treatment for social anxiety, according to this Depression and Anxiety review on escitalopram in social anxiety disorder
Meet With One of Our Treatment Specialists We'll answer any questions you have, explain our treatments in detail, and create a customized treatment plan just for you
Brightening Antioxidant Detox
Arthroscopy the Journal of Arthroscopic and Related Surgery